Check out this link that I got from the CELG site. Wells Fargo lists milestones for CELG. Interesting they list the Dacogen AML results due in H 2010 and that there will be what appears to be a Vidaza trial in AML for 300 patients. Seems like Vidaza is behind Dacogen on this. Am I reading this correctly?
Seems like Vidaza is behind Dacogen on this. Am I reading this correctly?
If you mean that celg is worried or wants in on the market then yes. However if dacogen doesn't have decent results and cannot received approval, celg will corner that area too. Supg stock is reacting like a failure to the trial is coming and if its true, another disappointment. Just hope eisai and J&J can turn dacogen around.